This content is machine translated Chronic urticaria “Treat-to-target” approach is underpinned by new findings The treatment arsenal for chronic urticaria includes several 2nd generation antihistamines – still the treatment of first choice – the monoclonal antibody Omalizumab and the immunosuppressant Ciclosporin A as an…
View Post 8 min This content is machine translated Psoriasis vulgaris Practice-oriented recommendations for system therapy Fortunately, developments in recent years have led to the effective treatment of many patients with moderate to severe psoriasis. In addition to classical immunosuppressants, several biologics and a small molecule…
View Post 3 min This content is machine translated Atopic dermatitis Dupilumab not only reduces primary symptoms Comorbid psychological symptoms are common in atopic dermatitis and can have serious consequences. The IgG4 monoclonal antibody dupilumab led to significant symptom reduction in subpopulations of this patient population, resulting…
